UK Stocks-Factors to watch on Nov 30

Nov 30 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Tuesday with futures .FFIc1 down 1.1%.

* WISE PLC: Money transfer company Wise Plc WISEa.L said its revenue was 256.3 million pounds in the six months to Sept 30, a rise of 33% from the same period last year.

* MARSTON'S: Pub operator Marston's Plc MARS.L posted a bigger annual loss and withheld dividend, citing potential for continuing uncertainty.

* SHAFTESBURY: West End-focused commercial landlord Shaftesbury Plc SHB.L reported a smaller annual loss, as people returning to London lifted the prospect of its core tenant base of hospitality firms and fashion retailers.

* EASYJET: Airline easyJet EZJ.L said it had seen some softening of trading in the first quarter following the emergence of the Omicron variant, but it remained well placed to handle uncertainty through its financial year.

* WETHERSPOON: British pubs chain JD Wetherspoon JDW.L said on Tuesday it had had "a generally favourable response" from institutional shareholders to its corporate governance, after concerns were raised about the length of time served by some board members.

* TOPPS TILES: Tile retailer Topps Tiles TPT.L on Tuesday resumed dividend payouts as full-year profit jumped more than four-fold, driven by demand from people redoing their homes during the pandemic.

* MICRO FOCUS: Micro Focus International MCRO.L laid out a target to end 2023 with flat or slight revenue growth, compared with a provisional 5% decline this year, as the British software firm reaps the benefits of a turnaround plan it launched last year.

* INFLATION: Costs are rising at the fastest rate in over 20 years for firms in Britain's services sector, according to a business survey released which shows why the Bank of England may soon raise interest rates.

* OIL: Oil prices gave up gains, falling more than 2% along with broader financial markets, after a media report cast doubt on the efficacy of COVID-19 vaccines against the Omicron coronavirus variant.

* London's FTSE 100 bounced back from its worst session in more than a year to rise on Monday as investors kept a wary eye on the newly detected Omicron coronavirus variant.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

(Reporting By Amna Karimi in Bengaluru)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.